In oncology, the earliest diagnosis offers the highest probability of complete cure. Over 50% of cancers are preventable or completely curable if identified at an asymptomatic or pre-cancerous stage. At Precision Cancer Research Institute (PCRI), Preventive Oncology is an indispensable wing dedicated to proactive risk assessment, lifestyle counseling, hereditary genetic screening, and evidence-based cancer screening packages for the general community.
Our screening programs are designed in alignment with international guidelines (WHO, NCCN, and ASCO) to detect cellular abnormalities long before clinical symptoms manifest.
Clinical Breast Examination (CBE), referral for digital high-resolution mammography, breast ultrasound for younger women with dense breast tissue, and hereditary risk assessment (BRCA1/2 gene testing) for individuals with a family history.
Liquid-Based Cytology (LBC) Pap smears and High-Risk Human Papillomavirus (HPV DNA) co-testing. Early identification of cervical intraepithelial neoplasia (CIN) enables curative outpatient treatment. We also provide HPV vaccination guidance for adolescent girls and young women.
Surat and South Gujarat have high rates of tobacco and areca nut consumption. PCRI provides detailed oral cavity mucosal mapping to detect pre-malignant lesions early — including Leukoplakia, Erythroplakia, and Oral Submucous Fibrosis (OSMF) — preventing malignant transformation into aggressive oral squamous cell carcinoma.
Annual Fecal Immunochemical Testing (FIT) for occult micro-bleeding and screening colonoscopy referrals for adults above 45 years or those with hereditary polyposis syndromes (Lynch syndrome).
Serum Prostate-Specific Antigen (Total PSA) blood testing and clinical digital examinations for men aged 50 and above (or 45 for those with high familial risk).
Low-Dose Computed Tomography (LDCT) chest scans for chronic cigarette, bidi, or industrial exposure individuals.